Embrace Hydrogel Embolic System (HES)
FDA premarket approval P250003/S002 · decided 2025-12-17
Approval details
- PMA number
- P250003
- Supplement
- S002
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Embrace Hydrogel Embolic System (HES)
- Generic name
- Embolization Agent, Vascular
- Applicant
- Instylla, Inc.
- Date received
- 2025-11-18
- Decision date
- 2025-12-17
- Days to decision
- 29 days
- Decision code
- OK30
- Product code
- QVG
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Bedford, MA
- Statement
- to update to the PEG percent substitution test method, the Laysan Bio Manufacturing process for PEG, and process specifications by the steam sterilization supplier, Steris
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| Verge™ Microcatheter (K261610) | Instylla, Inc. | 2026-06-11 |
| Instylla Delivery Kit (K253769) | Instylla, Inc. | 2025-12-22 |
| Tembo Embolic System (K253677) | Instylla, Inc. | 2025-12-15 |
| TEMBO Embolic System (K240873) | Instylla, Inc. | 2024-12-16 |
| Instylla Delivery Kit (K213632) | Instylla, Inc. | 2022-02-10 |
| Instylla Microcatheter 1.2 (K210808) | Instylla, Inc. | 2021-04-15 |
| Instylla Delivery Kit (K202544) | Instylla, Inc. | 2021-01-07 |
| Instylla Microcatheter (K200744) | Instylla, Inc. | 2020-04-21 |